![Michael Wheatcroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Wheatcroft
Director Técnico/Científico/I+D en
TELIX PHARMACEUTICALS LIMITED
.
Perfil
Michael Wheatcroft currently works at Telix Pharmaceuticals Ltd., as Chief Scientist from 2021.
Dr. Wheatcroft also formerly worked at MedImmune U.K.
Ltd., as Principal and Avipep Pty Ltd., as Research Manager.
Dr. Wheatcroft received his doctorate degree from the University of Cambridge.
Cargos activos de Michael Wheatcroft
| Empresas | Cargo | Inicio |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Michael Wheatcroft.
| Empresas | Cargo | Fin |
|---|---|---|
MedImmune U.K. Ltd.
 MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Corporate Officer/Principal | - |
Avipep Pty Ltd.
 Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Corporate Officer/Principal | - |
Formación de Michael Wheatcroft.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
22
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedImmune U.K. Ltd.
MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Health Technology |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
- Bolsa de valores
- Insiders
- Michael Wheatcroft
